| From lab to living room: mRNA therapeutics Forbes: Pamela Davis, the Arline H. and Curtis F. Garvin Research Professor at the School of Medicine, said therapeutic use of mRNA offers great promise for diseases that occur due to a missing or dysfunctional protein. “The half dozen diseases now being treated experimentally with mRNA should inform our strategy for other rare diseases and offer hope to many patients,” she said. “For diseases that arise from a missing or dysfunctional protein, treatment with mRNA encoding the missing protein could direct cells to manufacture that protein, and use the cell’s own machinery to modify the protein appropriately after it is made.” |
